Variables | OFA group (n = 55) | OA group (n = 55) | P-value |
---|---|---|---|
Age, (years) | 69 (62–74) | 69 (65–74) | 0.066 |
Gender (M), n (%) | 43 (78) | 35 (64) | 0.115 |
Body mass index (kg m −2) | 26 (24–30) | 26 (23–30) | 0.162 |
ASA, n (%) | |||
 2 | 3 (5) | 7 (12) |  |
 3 | 41 (75) | 38 (69) |  |
 4 | 11 (20) | 10 (19) |  |
EuroSCORE II (%) | 1.51 (0.98–3.1) | 1.69 (0.87–3.01) | 0.805 |
Euroscore (%) | 6 (5–9) | 6 (3–8) | 0.238 |
Medical history, n (%) | |||
 Coronary disease | 31 (56) | 27 (49) | 0.571 |
 Arrhythmia | 8 (14) | 13 (24) | 0.332 |
 Dyslipidaemia | 31 (56) | 34 (62) | 0.556 |
 Smoking history | 23 (42) | 19 (35) | 0.556 |
 High blood pressure | 42 (76) | 43 (77) | 1 |
 Diabetes | 15 (27) | 15 (27) | 1 |
 Chronic renal insufficiency | 12 (22) | 7 (13) | 0.276 |
 Stroke | 4 (7) | 4 (7) | 1 |
 Obstructive sleep apnoea | 7 (13) | 7 (13) | 1 |
Treatment, n (%) | |||
 Beta blocker | 34 (62) | 34 (62) | 1.00 |
 Calcic channel blocker | 9 (16) | 6 (11) | 0.581 |
 Aspirin | 32 (58) | 28 (49) | 0.596 |
 Clopidogrel | 2 (4) | 6 (11) | 0.261 |
 Angiotensin enzyme converting inhibitor | 21 (38) | 23 (42) | 0.832 |
 Statin | 32 (58) | 34 (62) | 0.832 |
 Diuretics | 21 (38) | 19 (35) | 0.850 |
Left Ventricular Ejection Fraction (%) | 60 (51–65) | 60 (50–65) | 0.278 |
Creatinine (mmol l−1) | 83 (72–96) | 84 (70–98) | 0.558 |